Ido Weinberg, MD (@angiologist) 's Twitter Profile
Ido Weinberg, MD

@angiologist

Vascular MD @MassGeneralNews. VASCORE.org. Prez @SVM_tweets. angiologist.com. YouTube.com/Angiologist. The Machine is God.

ID: 242153194

linkhttps://www.almasmatters.com/ calendar_today24-01-2011 02:33:00

9,9K Tweet

5,5K Followers

442 Following

Ido Weinberg, MD (@angiologist) 's Twitter Profile Photo

Peripheral artery disease (PAD), common and serious, doesn't receive enough attention. Many people suffer leg symptoms with walking, but never receive appropriate care. I made this video to help #patients understand what to do: youtu.be/9-f5SESI7a4?si… Gaurav Parmar Mass General Vascular

manuel monreal (@mmonrealriete) 's Twitter Profile Photo

Among 244 VTE patients with severe renal failure receiving enoxaparin for 6 months, VTE recurrences were less common than major bleeding: 4.1 vs. 13% But during the first 10 days, fatal PE was 5-fold more common than fatal bleeding: 2.1 vs. 0.4% Here: pubmed.ncbi.nlm.nih.gov/37832588/

Among 244 VTE patients with severe renal failure receiving enoxaparin for 6 months, VTE recurrences were less common than major bleeding: 4.1 vs. 13%

But  during the first 10 days, fatal PE was 5-fold more common than fatal bleeding: 2.1 vs. 0.4%

Here: pubmed.ncbi.nlm.nih.gov/37832588/
Society for Vascular Medicine | SVM (@svm_tweets) 's Twitter Profile Photo

EKOS vs Flowtriever thrombectomy is not always a straightforward decision. Risk of bleeding 🩸 is REAL for both groups although no difference in 30-day readmission, in-hospital death, or ischemic strokes. mcusercontent.com/a8631a3042d8dd… #VascMedJC #SVM VascularMedicine Vladimir Lakhter

EKOS vs Flowtriever thrombectomy is not always a straightforward decision. Risk of bleeding 🩸 is REAL for both groups although no difference in 30-day readmission, in-hospital death, or ischemic strokes. 

mcusercontent.com/a8631a3042d8dd…

#VascMedJC #SVM <a href="/VMJ_SVM/">VascularMedicine</a> <a href="/VladLakhter/">Vladimir Lakhter</a>
manuel monreal (@mmonrealriete) 's Twitter Profile Photo

20 years ago, cancer patients with VTE had similar rates of 30-day recurrence or major bleeding during anticoagulation Nowadays, major bleeds are 2-fold more common than VTE recurrences Safety is the issue

20 years ago, cancer patients with VTE had similar rates of 30-day recurrence or major bleeding during anticoagulation 

Nowadays, major bleeds are 2-fold more common than VTE recurrences

Safety is the issue
manuel monreal (@mmonrealriete) 's Twitter Profile Photo

Patients with brain cancer have a much higher risk for intracranial bleeding during anticoagulation for VTE Find it here: rpthjournal.org/action/showPdf…

Patients with brain cancer have a much higher risk for intracranial bleeding during anticoagulation for VTE

Find it here: rpthjournal.org/action/showPdf…
Society for Vascular Medicine | SVM (@svm_tweets) 's Twitter Profile Photo

Are you interested in #Cardiology #VascularSurgery #VascularMedicine #IR ? Don’t miss this amazing learning opportunity for #residents #fellows #APPs ! Registration is now OPEN! Join #SVM & register today veritasamc.us16.list-manage.com/track/click?u=… Heather L Gornik Aditya Sharma Raghu Kolluri

Are you interested in #Cardiology #VascularSurgery #VascularMedicine #IR ? 

Don’t miss this amazing learning opportunity for #residents #fellows #APPs !

Registration is now OPEN! 
Join #SVM &amp; register today veritasamc.us16.list-manage.com/track/click?u=…

<a href="/heatherlgornik/">Heather L Gornik</a> <a href="/adityasharmamd/">Aditya Sharma</a> <a href="/RKolluriMD/">Raghu Kolluri</a>
Ido Weinberg, MD (@angiologist) 's Twitter Profile Photo

I often don't know what to do with high-sensitivity troponin. Congratulations Behnood Bikdeli et al. for helping confirm our suspicion that we should take it with a grain of salt... jamanetwork.com/journals/jamac… The PERT Consortium® Gaurav Parmar Andrew Dicks maybe a Society for Vascular Medicine | SVM JC paper? ;)

I often don't know what to do with high-sensitivity troponin.  Congratulations <a href="/bbikdeli/">Behnood Bikdeli</a> et al. for helping confirm our suspicion that we should take it with a grain of salt...

jamanetwork.com/journals/jamac… <a href="/PERTConsortium/">The PERT Consortium®</a> <a href="/GParmar_MD/">Gaurav Parmar</a> 

<a href="/AndrewDicksMD/">Andrew Dicks</a> maybe a <a href="/SVM_tweets/">Society for Vascular Medicine | SVM</a> JC paper? ;)
Society for Vascular Medicine | SVM (@svm_tweets) 's Twitter Profile Photo

It’s not just “go home & walk” Home based walking exercise does work if done right. Coaching & connecting with patients is also crucial. It was incredible to have Dr McDermott & Neela Thangada , the lead authors of the article, join the discussion! Alexander Vakili Emory Cardiology #SVM

It’s not just “go home &amp; walk”
Home based walking exercise does work if done right. Coaching &amp; connecting with patients is also crucial.

It was incredible to have Dr McDermott &amp; <a href="/CardioNeela/">Neela Thangada</a> , the lead authors of the article,  join the discussion!
<a href="/AlexVakiliMD/">Alexander Vakili</a> <a href="/emoryheart/">Emory Cardiology</a> #SVM
Ido Weinberg, MD (@angiologist) 's Twitter Profile Photo

Avoid this MISTAKE in BLOOD PRESSURE measurement*,** youtu.be/mf4OsX4Nr6A?si… *Ok. I hate clickbait too. Measure BP in BOTH arms. But still, watch the short clip, LIKE, SHARE, SUBSCRIBE. **Yup. That's my BP, HR and hair... Eric Secemsky MD MSc Gaurav Parmar Vladimir Lakhter Society for Vascular Medicine | SVM

VascularMedicine (@vmj_svm) 's Twitter Profile Photo

Online First! DocBuso and colleagues share humbling data suggesting high rates of symptomatic vascular events in patients with vascular Ehlers-Danlos syndrome despite celiprolol therapy. #VEDS #VEDSAwarenss

Online First! <a href="/GiacomoBuso/">DocBuso</a> and colleagues share humbling data suggesting high rates of symptomatic vascular events in patients with vascular Ehlers-Danlos syndrome despite celiprolol therapy. 
#VEDS #VEDSAwarenss
VascularMedicine (@vmj_svm) 's Twitter Profile Photo

From the current issue: Primary results of the SAVAL randomized trial. buff.ly/3tHlVUo #CLTI #PeripheralArteryDisease #VascularTwitter

From the current issue: Primary results of the SAVAL randomized trial.
buff.ly/3tHlVUo
#CLTI #PeripheralArteryDisease #VascularTwitter